A blinded validation of the Swedish version of the Clinical Assessment Interview for Negative Symptoms (CAINS)

References

• Galderisi S, Mucci A, Buchanan RW, et al. Negative symptoms of schizophrenia: new developments and unanswered research questions. Lancet Psychiatry. 2018;5(8):664–677.
   PubMed Web of Science ®Google Scholar
• Fervaha G, Foussias G, Agid O, et al. Impact of primary negative symptoms on functional outcomes in schizophrenia. Eur Psychiatry. 2014;29(7):449–455.
   PubMed Web of Science ®Google Scholar
• Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373(9657):31–41.
   PubMed Web of Science ®Google Scholar
• Tiihonen J, Mittendorfer-Rutz E, Majak M, et al. Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29,823 patients with schizophrenia. JAMA Psychiatry. 2017;74(7):686–693.
   PubMed Web of Science ®Google Scholar
• Fusar-Poli P, Papanastasiou E, Stahl D, et al. Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials. Schizophr Bull. 2015;41(4):892–899.
   PubMed Web of Science ®Google Scholar
• Overall JE, Gorham DR. The Brief Psychiatric Ratings Scale. Psychol Rep. 1962;10(3):799–812.
   Web of Science ®Google Scholar
• Ventura J, Green M, Shaner A, et al. Training and quality assurance with the brief psychiatric rating scale: 'The Drift Busters.’ Int J Meth Psych Res. 1993;3:221–244.
   Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276.
   PubMed Web of Science ®Google Scholar
• Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry. 1989;155(S7):49–58.
   Google Scholar
• Lincoln TM, Dollfus S, Lyne J. Current developments and challenges in the assessment of negative symptoms. Schizophr Res. 2017;186:8–18.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Fenton WS, Carpenter WT, Jr, et al. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32(2):214–219.
   PubMed Web of Science ®Google Scholar
• Blanchard JJ, Kring AM, Horan WP, et al. Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr Bull. 2011;37(2):291–299.
   PubMed Web of Science ®Google Scholar
• Forbes C, Blanchard JJ, Bennett M, et al. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophr Res. 2010;124(1-3):36–42.
   PubMed Web of Science ®Google Scholar
• Horan WP, Kring AM, Gur RE, et al. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophr Res. 2011;132(2–3):140–145.
   PubMed Web of Science ®Google Scholar
• Kring AM, Gur RE, Blanchard JJ, et al. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am J Psychiatry. 2013;170(2):165–172.
   PubMed Web of Science ®Google Scholar
• Strauss GP, Gold JM. A psychometric comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale. Schizophr Bull. 2016;42(6):1384–1394.
   PubMed Web of Science ®Google Scholar
• Engel M, Fritzsche A, Lincoln TM. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS). Psychiatry Res. 2014;220:659–663.
   PubMed Web of Science ®Google Scholar
• Chan RC, Shi C, Lui SS, et al. Validation of the Chinese version of the Clinical Assessment Interview for Negative Symptoms (CAINS): a preliminary report. Front Psychol. 2015;6:7.
   PubMed Web of Science ®Google Scholar
• Valiente-Gomez A, Mezquida G, Romaguera A, et al. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS). Schizophr Res. 2015;166(1–3):104–109.
   PubMed Web of Science ®Google Scholar
• Jang SK, Park SC, Choi KH, et al. Validation of the Korean Version of the Clinical Assessment Interview for Negative Symptoms. Psychiatry Investig. 2017;14(4):413–419.
   PubMed Web of Science ®Google Scholar
• Jung SI, Woo J, Kim YT, et al. Validation of the Korean-version of the Clinical Assessment Interview for Negative Symptoms of Schizophrenia (CAINS). J Korean Med Sci. 2016;31(7):1114–1120.
   PubMed Web of Science ®Google Scholar
• Ristic I, Jerotic S, Zebic M, et al. Factorial structure of the Serbian version of the Clinical Assessment Interview for Negative Symptoms – evidence for three factors of negative symptoms. Front Psychol. 2020;11:570356.
   PubMed Web of Science ®Google Scholar
• Rekhi G, Ang MS, Yuen CKY, et al. Assessing negative symptoms in schizophrenia: validity of the clinical assessment interview for negative symptoms in Singapore. Schizophr Res. 2019;206:177–182.
   PubMed Web of Science ®Google Scholar
• Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
   PubMedGoogle Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.
   PubMed Web of Science ®Google Scholar
• Whiting PF, Weswood ME, Rutjes AW, et al. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006;6:9.
   PubMedGoogle Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.
   PubMed Web of Science ®Google Scholar
• Llerena K, Park SG, McCarthy JM, et al. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms. Compr Psychiatry. 2013;54(5):568–574.
   PubMed Web of Science ®Google Scholar
• Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol. 1999;14(2):167–177.
   PubMed Web of Science ®Google Scholar
• Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 2007;64(5):532–542.
   PubMed Web of Science ®Google Scholar
• Shafer A, Dazzi F, Ventura J. Factor structure of the Brief Psychiatric Rating Scale – Expanded (BPRS-E) in a large hospitalized sample. J Psychiatr Res. 2017;93:79–86.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389.
   PubMed Web of Science ®Google Scholar
• Guy W. 1976. ECDEU assessment manual for psychopharmacology publication. Washington DC, USA: Department of Health, Education and Welfare.
   Google Scholar
• Group TE. A new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
   PubMed Web of Science ®Google Scholar
• Chouinard G, Margolese HC. Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res. 2005;76(2–3):247–265.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl 3):89–95.
   PubMed Web of Science ®Google Scholar
• Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420–428.
   PubMed Web of Science ®Google Scholar
• Cronbach LJ, Warrington WG. Time-limit tests: estimating their reliability and degree of speeding. Psychometrika. 1951;16(2):167–188.
   PubMedGoogle Scholar
• Revelle W. 2021. Psych: procedures for psychological, psychometric, and personality research. R package version 2.1.3. Evanston, Illinois: Northwestern University.
   Google Scholar
• Gardner DM, Murphy AL, O'Donnell H, et al. International consensus study of antipsychotic dosing. AJP. 2010;167(6):686–693.
   Google Scholar
• Staniszewska S, Denegri S, Matthews R, et al. Reviewing progress in public involvement in NIHR research: developing and implementing a new vision for the future. BMJ Open. 2018;8(7):e017124.
   PubMed Web of Science ®Google Scholar
• Richter J, Holz L, Hesse K, et al. Measurement of negative and depressive symptoms: Discriminatory relevance of affect and expression. Eur Psychiatr. 2019;55:23–28.
   PubMed Web of Science ®Google Scholar
• Foussias G, Agid O, Fervaha G, et al. Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders. Eur Neuropsychopharmacol. 2014;24(5):693–709.
   PubMed Web of Science ®Google Scholar
• Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res. 1990;3(4):247–251.
   PubMed Web of Science ®Google Scholar
• Rossi S, Hallett M, Rossini PM, et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008–2039.
   PubMed Web of Science ®Google Scholar